Table 3.
Clinical response of immune checkpoint inhibitors.
| ORR | DCR | Median PFS (months) | |
|---|---|---|---|
| First line (n = 7) | 5 (71.4%) | 7 (100%) | 7.5 |
| Subsequent line (n = 9) | 1 (11%) | 6 (66.7%) | 4.7 |
| PD-L1 positive (n = 8) | 3 (37.5%) | 6 (75%) | 6.6 |
| PD-L1 negative or unknown (n = 8) | 3 (37.5%) | 7 (87.5%) | 6.1 |
| PD-L1 high (≥50%) (n = 4) |
3 (75%) | 4 (100%) | 5.6 |
Abbreviations: ORR: objective response rate. DCR: disease control rate. PFS: progression-free survival.